
GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier
Keywords: اینترلوکین; CD; Crohn's disease; DSS; dextran sodium sulphate; EDTA; ethylenediaminetetraacetic acid; GLPâ2; glucagonâlike peptide 2; IFNγ; interferon gamma; IL; interleukin; IGF; insulin growth factor; MAGUK; membrane associated guanylate kinase; MLCK; myosin l